The latest price target for Dynavax Technologies (NASDAQ:DVAX) was reported by Citizens Capital Markets on February 21, 2025. The analyst firm set a price target for $33.00 expecting DVAX to rise to within 12 months (a possible 141.05% upside). 11 analyst firms have reported ratings in the last year.

The latest analyst rating for Dynavax Technologies (NASDAQ:DVAX) was provided by Citizens Capital Markets, and Dynavax Technologies maintained their market outperform rating.

There is no last upgrade for Dynavax Technologies

The last downgrade for Dynavax Technologies Corp happened on February 11, 2025 when Goldman Sachs changed their price target from $15 to $12 for Dynavax Technologies Corp.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dynavax Technologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dynavax Technologies was filed on February 21, 2025 so you should expect the next rating to be made available sometime around February 21, 2026.

While ratings are subjective and will change, the latest Dynavax Technologies (DVAX) rating was a maintained with a price target of $29.00 to $33.00. The current price Dynavax Technologies (DVAX) is trading at is $13.69, which is out of the analyst’s predicted range.